🎉 Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application

NxBar: Phase 2

Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application 🎉

Scroll to Top